AREA OF INTEREST

• Pathogenesis, diagnosis and management of Mycobacterium ulcerans disease (Buruli ulcer)
• Co-infection of HIV with Hepatitis B, C, D,E virus co-infection
• Coinfection of M ulcerans disease and M perstans filariasis
• HIV, Tuberculosis
• Hepatitis C infection

AREA OF SPECIALTY

• INTERNAL MEDICINE
• INFECTION AND IMMUNITY

RESEARCH INTEREST

• Mycobacterial diseases (M. ulcerans infection, Tuberculosis)
• Coinfection (HBV/HIV, Mycobacteria/filarial)
• Mansonella Perstans disease
• HIV
• HCV infection
• Yaws

INSTITUTIONS ATTENDED

• Kwame Nkrumah University of Science and Technology, 1987-1993
• University of London, St Georges University of London, UK, March 2002-August 2005

QUALIFICATIONS

• Fellow of Ghana College of Physicians (FGCP) West African Postgraduate Medical College, December 2013
• Fellow of West African College of Physicians (FWACP) West African Postgraduate Medical College, October 2008
• Member of West African College of Physicians (MWACP) West African Postgraduate Medical College, October 2006
• Doctor of Philosophy (PhD), University of London, St George’s University of London August 2005
• MB ChB. Kwame Nkrumah University of Science and Technology, Nov 1993
• BSc (Human Biology) Kwame Nkrumah University of Science and Technology, 1990

EMPLOYMENT & POSITION HELD/HOLD

• February 2012- August 2013: Coordinator of Clinical Programme: School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi
• September 2011- August 2013: Clinical Examinations Officer: School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi
• September 2011- August 2013: Education Committee Member: School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi
• September 2011- August 2013: School Board Member: School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi
• October 2010- date: Senior lecturer: Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology
• April 2007- September 2010: Research Fellow: Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology
• October 2008: Senior Specialist, Komfo Anokye Teaching Hospital, Kumasi
• October 2006: Physician Specialist, Komfo Anokye Teaching Hospital, Kumasi
• March 1997-February 2002: Senior Medical Officer/Resident, Department of Medicine KATH
• March, 1997 –Feb 1998:Medical Officer, Department of Medicine, KATH
• Feb, 1996 –Feb 1997, Rotations in Obstetrics and Gynaecology and Child Health6.August 1995-Jan 1996, House officer, Department of Surgery, KATH
• Feb 1995-July 1995, House Officer, Department of Medicine, KATH

ASSOCIATIONS/AFFILIATIONS

• Ghana Medical Association
• Fellow, Ghana College of Physicians and Surgeons

HONOURS, AWARDS & ACHIEVEMENTS

• Award winner for MRC/DfID African Research Leader scheme 2012- 2017 on Pathogenesis and management of M. ulcerans disease, Buruli ulcer
• Leverhulme - Royal Society Africa Award. 2010-2013,. Research theme: HIV and Hepatitis B virus co-infection; Antiviral therapy and drug resistance; HIV genetic variability.
• Framework of the European Foundations Initiative on Neglected Tropical Diseases promoted by Calouste Gulbenkian Foundation, Volkswagen Foundation, Merieux Foundation,Nuffield Foundation and Cariplo Foundation award 2008-2011
• Ghana-Tanzania-UK Royal society networking award 28-29th April 2008
• Wellcome Trust Value In People Award, Cellular and Molecular Medicine (Infectious Diseases) St George’s University of London, London, U.K, March 2005-October 2005
• Wellcome Trust Training Research Fellowship for Scientists from Developing Countries, UK, March 2002-Fedruary 2005
• British Infection Society Award Spring Meeting. London, UK March 2003,
• Best Doctor Award for exemplary performance of duty, Department of Medicine, 1995

PROFESSIONAL / TEACHING EXPERIENCE

• October 2010- date: Senior lecturer: Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology
• April 2007- September 2010: Research Fellow: Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology
• October 2008: Senior Specialist, Komfo Anokye Teaching Hospital, Kumasi
• October 2006: Physician Specialist, Komfo Anokye Teaching Hospital, Kumasi
• March 1997-February 2002: Senior Medical Officer/Resident, Department of Medicine KATH
• March, 1997 –Feb 1998:Medical Officer, Department of Medicine, KATH
• Feb, 1996 –Feb 1997, Rotations in Obstetrics and Gynaecology and Child Health6.August 1995-Jan 1996, House officer, Department of Surgery, KATH
• Feb 1995-July 1995, House Officer, Department of Medicine, KATH

PUBLICATIONS

• Phillips R, Horsfield C, Kuijper S, Lartey A, Tetteh I, Etuaful S, Nyamekye, B, Awuah P, Nyarko KM, Osei-Sarpong F, Lucas S, Kolk AH, Wansbrough-Jones M. Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer. J Clin Microbiol. 2005 Aug;43(8):3650-6. 
  >>Read
• Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother. 2005 Aug;49(8):3182-6. 
  >>Read
• Wansbrough-Jones M, Phillips R. Buruli ulcer. BMJ. 2005 Jun18;330(7505):1402-3. PubMed PMID: 15961795; PubMed Central PMCID: PMC558362. 
  >>Read
• Thangaraj HS, Phillips RO, Evans MR, Wansbrough-Jones MH. Emerging aspects of Buruli ulcer. Expert Rev Anti Infect Ther. 2003 Aug;1(2):217-22. Review. 
  >>Read
• Phillips R, Kuijper S, Benjamin N, Wansbrough-Jones M, Wilks M, Kolk AH. In vitro killing of Mycobacterium ulcerans by acidified nitrite. Antimicrob Agents Chemother. 2004 Aug;48(8):3130-2. 
  >>Read
• Phillips R, Adjei O, Lucas S, Benjamin N, Wansbrough-Jones M. Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides. Antimicrob Agents Chemother. 72004 Aug;48(8):2866-70 
  >>Read
• Evans MR, Phillips R, Etuaful SN, Amofah G, Adomako J, Adjei O, Dennis-Antwi J, Lucas SB, Wansbrough-Jones MH. An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease. Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):159-60 
  >>Read
• Plange-Rhule J, Phillips R, Acheampong JW, Saggar-Malik AK, Cappuccio FP, Eastwood JB. Hypertension and renal failure in Kumasi, Ghana. J Hum Hypertens. 1999 Jan;13(1):37-40 
  >>Read
• Cappuccio FP, Plange-Rhule J, Phillips RO, Eastwood JB. Prevention of hypertension and stroke in Africa. Lancet. 2000 Aug 19;356(9230):677-8. 
  >>Read
• Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, Phillips RO, Plange-Rhule J, Eastwood JB. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004 May;43(5):1017-22 
  >>Read
• Kerry SM, Emmett L, Micah FB, Martin-Peprah R, Antwi S, Phillips RO, Plange-Rhule J, Eastwood JB, Cappuccio FP. Rural and semi-urban differences in salt intake, and its dietary sources, in Ashanti, West Africa. Ethn Dis. 2005 Winter;15(1):33-9. 
  >>Read
• Kerry SM, Emmett L, Micah FB, Martin-Peprah R, Antwi S, Phillips RO,Plange-Rhule J, Eastwood JB, Cappuccio FP. For the patient. How much salt is used in Ashanti, West Africa? Ethn Dis. 2005 Winter;15(1):150-1 
  >>Read
• Phillips, R., C. Horsfield, S. Kuijper, S. F. Sarfo, J. Obeng-Baah, S. Etuaful, B. Nyamekye, P. Awuah, K. Nyarko, F. Osei-Sarpong, S. Lucas, A. H. J. Kolk, and Wansbrough-Jones. M. 2006. Cytokine response to antigen stimulation of whole blood in M. ulcerans disease compared to tuberculosis. Clinical and Vaccine Immunology (formerly Clinical Diagnostic Laboratory Immunology) 13(2): 253-25 
  >>Read
• Phillips R, Horsfield C, Mangan J, Laing K, Etuaful S, Nyamekye B, Awuah P, Nyarko K.M, Osei-Sarpong F, Butcher P, Lucas S, Wansbrough-Jones M. 2006. Cytokine mRNA expression in M. ulcerans infected human tissue; correlates with local inflammatory response. Infection and Immunity 74: 2917-24. 
  >>Read
• Wansbrough-Jones MH and Phillips R. Buruli ulcer: emerging out of obscurity 2006 The Lancet ; 367: 1849-58. 
  >>Read
• Cosgrove C, Castello-Branco L, Hussel T, Sexton A, Giemza R, Phillips R, Williams A, Griffin G, Dougan G, Lewis D. Boosting of Cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine 2006 Infection and Immunity 74 (4): 2449-2452. 2009 
  >>Read
• Sarfo FS, Bibby DF, Schwab U, Appiah LT, Clark DA, Collini P, Phillips R, Green I, Dittmar MT, Chadwick DR.Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.J Antimicrob Chemother. 2009 Sep;64(3):667-9. Epub 2009 Jun 23. 
  >>Read
• Phillips RO, Sarfo FS, Osei-Sarpong F, Boateng A, Tetteh I, Lartey A, Adentwe E, Opare W, Asiedu KB, Wansbrough-Jones M. Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer.J Clin Microbiol. 2009 Apr;47(4):924-6. Epub 2009 Feb 9. 
  >>Read
• Huygen K, Adjei O, Affolabi D, Bretzel G, Demangel C, Fleischer B, Johnson RC, Pedrosa J, Phanzu DM, Phillips RO, Pluschke G, Siegmund V, Singh M, van der Werf TS, Wansbrough-Jones M, Portaels F. Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol. 2009 May;198(2):69-77 
  >>Read
• Phillips R, Sarfo FS, Guenin-Macé L, Decalf J, Wansbrough-Jones M, Albert ML, Demangel C. Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. 
  >>Read
• J Infect Dis. 2009 Dec 1;200(11):1675-84. 
  >>Read
• Sarfo FS, Phillips RO, Ampadu E, Sarpong F, Adentwe E, Wansbrough-Jones M. Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans.
• Clin Vaccine Immunol. 2009 Jan;16(1):61-5. 
  >>Read
• Sarfo FS, Phillips RO, Rangers B, Mahrous EA, Lee RE, Tarelli E, et al. Detection of Mycolactone 
  >>Read
• A/B in Mycobacterium ulcerans-Infected Human Tissue. PLoS Negl Trop Dis. 2010;4(1):e577. 
  >>Read
• Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M, Garcia A, Phillips RO. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol. 2010 Sep;48(9):3223-30. 
  >>Read
• Sarfo FS, Phillips RO, Asiedu K, Ampadu E, Bobi N, Adentwe E, et al. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother. 2010 Sep;54(9):3678-85. 
  >>Read
• Mamoojee Y, Shakoor S, Gorton RL, Sarfo S, Appiah LT, Norman B, Balakrishnan I, Phillips RO, Chadwick D. Short Communication: Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana.Trop Med Int Health. 2011 Jan;16(1):53-6. doi: 10.1111/j.1365-3156.2010.02683.x. Epub 2010 Nov 10. 
  >>Read
• Sarfo FS, Lavender CJ, Fyfe JA, Johnson PD, Stinear TP, Phillips RO. 
  >>Read
• Mycobacterium ulcerans DNA not detected in faecal samples from Buruli ulcer patients: results of a pilot study. PLoS One. 2011 May 4;6(5):e19611. 
  >>Read
• Sarfo FS, Le Chevalier F, Aka N, Phillips RO, Amoako Y, Boneca IG, et al. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring. PLoS Negl Trop Dis. 2011 Jul;5(7):e1237. 
  >>Read
• Kariuki T, Phillips RO, Njenga S, Olesen OF, Klatser PR, Porro R, Lock S, Cabral MH, Gliber M, Hanne D. Research and capacity building for control of neglected tropical diseases: the need for a different approach. PLoS Negl Trop Dis. 2011;5(5):e1020. 
  >>Read
• Bates I, Phillips RO, Martin-Peprah R, Kibiki G, Gaye O, Phiri K, et al. Assessing and strengthening African universities' capacity for doctoral programmes. PLoS Med. 2011 Sep;8(9):e1001068 
  >>Read
• Mark Wansbrough-Jones, Richard O. Phillips 2012 Buruli ulcer chapter 2012 Hunter’s Tropical Medicine and Emerging Infectious disease 9th Ed: Elsevier Saunders ISBN978-1-4160-4390-4525-527 
  >>Read
• Mamoojee Y, Tan G, Gittins S, Sarfo S, Stephenson L, Carrington D, Bedu-Addo G, Phillips R, Appiah LT, Chadwick D Diagnosis of treponemal co-infection in HIV-infected West Africans. Trop Med Int Health. 2012 Sep 20 
  >>Read
• Chadwick D, Ankcorn M, Sarfo F, Phillips RO, Fox Z, Garcia A, et al. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana. J Antimicrob Chemother. 2012 Dec;67(12):2939-42 
  >>Read
• Beissner M, Symank D, Phillips RO, Amoako YA, Awua-Boateng NY, Sarfo FS, et al. Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay. PLoS Negl Trop Dis. 2012;6(8):e1756.2013 
  >>Read
• Chadwick D, Stanley A, Sarfo S, Appiah L, Ankcorn M, Foster G, Schwab U, Phillips R, Geretti AM.. Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa. AIDS. 2013 Jan 2;27(1):139-41. 
  >>Read
• Fred S. Sarfo , Rosie Keegan , Lambert Appiah ,Shaid Shakoor , Richard Phillips, Betty Norman,Yasmin Hardy, George Bedu-Addo, Lydia Longstaff, David R.Chadwick High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians Journal of Infection (2013) 67, 43e50 
  >>Read
• Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, et al. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol. 2013 Sep;58(1):18-23. 
  >>Read
• Sarfo, Fred; Yuan, Zhang; Egan, Deirdre; Appiah, Lambert; Phillips, Richard; Bedu-Addo, George; Sarfo, Maame; Khoo, Saye; Owen, Andrew Owen; Chadwick, David Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients 2014 Journal of antimicrobial chemotherapy J Antimicrob Chemother 2014;69:491-9. 
  >>Read
• Sarfo FS, Sarfo MA, Kasim A, Phillips R, Booth M, Chadwick D. Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana. J Antimicrob Chemother. 2014 ;69:254-61. 
  >>Read
• Karsor Kollie, Yaw Ampem Amoako, Julien Ake, Tarnue Mulbah, Fasseneh Zaizay,Mohammed Abass, Linda Lehman, Albert Paintsil, Fred Sarfo, Clement Lugala, Alexandre Tiendrebeogo, Richard Phillips, Kingsley Asiedu: Buruli ulcer in liberia, 2012.. Emerging Infectious Diseases 03/2014; 20(3). 
  >>Read
• Richard O. Phillips, Fred S. Sarfo , Mohammed K. Abass, Justice Abotsi , Tuah Wilson , Mark Forson, Yaw A. Amoako, William Thompson, Kingsley Asiedu, Mark Wansbrough-Jones Clinical and Bacteriological Efficacy of Combination of Rifampicin and Streptomycin for 2 weeks followed by Rifampicin and Clarithromycin for 6 weeks for treatment of Mycobacterium ulcerans disease Antimicrobial agents and chemotherapy. 2014 Feb;58(2):1161-6. 
  >>Read
• Jansson M, Beissner M, Phillips RO, Badziklou K, Piten E, Maman I, Sarfo FS, Huber KL, Rhomberg A, Symank D, Wagner M, Wiedemann F, Nitschke J, Banla Kere A, Herbinger KH, Adjei O, Löscher T, Bretzel G. Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease.J Clin Microbiol. 2014 Apr;52(4):1246-9. doi: 10.1128/JCM.03119-13. Epub 2014 Jan 29. 
  >>Read
• Koen Vandelannoote, Kurt Jordaens, Pieter Bomans, Herwig Leirs, Lies Durnez, Dissou Affolabi, Ghislain Sopoh, Julia Aguiar, Delphin Phanzu, Kibadi Kapay, Sara Eyangoh, Louis Bayonne Manou, Richard Odame Phillips, Anthony Ablordey, Leen Rigouts, Françoise Portaels, Miriam Eddyani, and Bouke de Jong Insertion Element - SNP typing provides insights into the population structure and evolution of the genetically monomorphic pathogen Mycobacterium ulcerans in Africa. Applied and environmental microbiology. 2014 Feb;80(3):1197-209. 
  >>Read
• Heather Williamson, Richard Phillips, Stephen Sarfo, and Pamela Small Genetic Diversity of PCR–positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana PloS one. 2014;9(2):e88007. 
  >>Read
• Klis S, Stienstra Y, Phillips RO, Abass KM, Tuah W, van der Werf TS. Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial. PLoS neglected tropical diseases. 2014 Mar;8(3):e2739. doi: 10.1371/journal.pntd.0002739. 
  >>Read
• Sarfo FS, Thompson W, Phillips RO, Paintsil A, Abass MK, Frimpong M, Abotsi J, Asiedu K, Wansbrough-Jones MH.A severe case of buruli ulcer disease with pleural effusions.PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2868. doi: 10.1371/journal.pntd.0002868. eCollection 2014 Jun..PMID: 24945409 
  >>Read
• Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, et al. (2014) Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease. PLoS Negl Trop Dis 8(4): e2786 
  >>Read
• Phillips RO, Frimpong M, Sarfo FS, Kretschmer B, Beissner M, Debrah A, Ampem-Amoako Y, Abass KM, Thompson W, Duah MS, Abotsi J, Adjei O, Fleischer B, Bretzel G, Wansbrough-Jones M, Jacobsen M. Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana. Emerg Infect Dis. 2014 Jun;20(6):1000-3. doi: 10.3201/eid2006.131501. PMID: 24857346 
  >>Read
• Fred S Sarfo, Richard O Phillips, Jihui Zhang, Mohammed K Abass, Justice Abotsi, Yaw A Amoako, Yaw Adu-Sarkodie, Clive Robinson, Mark H Wansbrough-Jones Kinetics of mycolactone in human skin during antibiotic therapy for Mycobacterium ulcerans disease BMC Infectious Diseases 2014, 14:202 (15 April 2014) 
  >>Read
• Sarfo FS, Sarfo MA, Norman B, Phillips R, Chadwick D Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph? PLoS One. 2014 Apr 11;9(4):e94854. doi: 10.1371/journal.pone.0094854. eCollection 2014. 
  >>Read
• Sandor K, van der Werf, TS, Phillips, R, Sarfo FS, Wansbrough-Jones, M, Y Stienstra Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice 2014 volume 28 issue 5 p797-798 
  >>Read
• Portaels F, Eddyani M, Lavender C, Phillips R, Bretzel G, Beissner M, Affolabi D 2014 Laboratory diagnosis of Buruli ulcer A Manual for Health Care Providers WHO 2nd Ed: WHO 
  >>Read
• Richard Phillips Contributor in Treatment of Mycobacterium ulcerans disease (Buruli ulcer) Guidance for Health Workers 2014 WHO 2nd Ed: WHO 
  >>Read
• Sandor Klis, Adelita Ranchor , Richard O. Phillips , Kabiru M. Abass , Wilson Tuah , Susanne Loth, Kristien Velding , Tjip S. van der Werf, Ymkje Stienstra Good Quality of Life in Former Buruli Ulcer Patients with Small Lesions: Long-Term Follow-up of the BURULICO Trial PLoS Negl Trop Dis 8(7): e2964 
  >>Read
• S. Geroult, R.O. Phillips, C. Demangel Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings Journal of Wound Care 2014. J Wound Care. 2014 Aug;23(8):417-8, 422-4. doi: 10.12968/jowc.2014.23.8.417. 
  >>Read
• Jennifer E. Layden, Richard Phillips, Ohene Opare-Sem, Adegboyega Akere, Babatunde L. Salako, Kenrad Nelson, Lara Dugas, Amy Luke, Bamidele O. Tayo, and Richard S. Cooper Hepatitis C in Sub-Saharan Africa: Urgent Need for Attention Open Forum Infect Dis (Summer 2014) 1 (2): doi:10.1093/ofid/ofu065 
  >>Read
• Sarfo FS, Kasim A, Phillips R, Geretti AM, Chadwick DR. and David R Chadwick Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana. Corresponding Author: Dr. David Chadwick J Infect. 2014 Jun 27. pii: S0163-4453(14)00190-X. doi: 10.1016/j.jinf.2014.06.012
• Abass, Kabiru; van der Werf, Tjip; Phillips, Richard; Sarfo, Fred; Abotsi, Justice; Mireku, Samuel; Thompson, William; Asiedu, Kingsley; Stienstra, Ymkje; Klis, Sandor-Adrian Buruli ulcer control in a highly endemic district in Ghana: role of community-based surveillance volunteers American Journal of Tropical Medicine & Hygiene Am J Trop Med Hyg. 2014 Oct 20. pii: 14-0405
• Richard O. Phillips, Fred S. Sarfo , Mohammed K. Abass, Justice Abotsi , Michael Frimpong, Edwin Ampadu, Mark Forson, Yaw A. Amoako, William Thompson, Kingsley Asiedu, Mark Wansbrough-Jones Reply to ““ Compliance with antimicrobial therapy for Buruli ulcer”. Antimicrobial Agents and Chemotherapy Antimicrob Agents Chemother. 2014 Oct;58(10):6341. doi: 10.1128/AAC.03874-14
• Sarfo FS, Sarfo MA, Norman B, Phillips R, Bedu-Addo G, Chadwick D. Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term antiretroviral therapy. PLoS ONE. 2014. October 2014 | Volume 9 | Issue 10 | e111400
• de Zeeuw J, Omansen TF, Douwstra M, Barogui YT, Agossadou C, Sopoh GE, Phillips RO, Johnson C, Abass KM, Saunderson P, Dijkstra PU, van der Werf TS, Stientstra Y. Persisting Social Participation Restrictions among Former Buruli Ulcer Patients in Ghana and Benin. PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3303. doi: 10.1371/journal.pntd.0003303 
  >>Read
• de Zeeuw J, Douwstra M, Omansen TF, Sopoh GE, Johnson C, Phillips RO, Alferink M, Saunderson P, Van der Werf TS, Dijkstra PU, Stienstra Y. Psychometric Properties of the Participation Scale among Former Buruli Ulcer Patients in Ghana and Benin. PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3254. doi: 10.1371/journal.pntd.0003254. 
  >>Read
• S. King, K. Adjei-Asante, L. Appiah, D. O. Adinku, A. Beloukas, M. Atkins, S. F. Sarfo, D. Chadwick, R. O. Phillips and A. M. Geretti Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana. Journal of Viral Hepatitis, 2014 doi:10.1111/jvh.12354 
  >>Read
• Layden JE, Phillips RO, Owusu-Ofori S, Sarfo FS, Kliethermes S, Mora N, Owusu 
  >>Read
• D, Nelson K, Opare-Sem O, Dugas L, Luke A, Shoham D, Forbi JC, Khudyakov YE,
• Cooper RS. High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways. Clin Infect Dis. 2014 Dec 4. pii: ciu965. [Epub ahead of print] PubMed PMID: 25477425.
• Phillips RO, Phanzu DM, Beissner M, Badziklou K, Luzolo EK, Sarfo FS, Halatoko WA, Amoako Y, Frimpong M, Kabiru AM, Piten E, Maman I, Bidjada B, Koba A, AwoussiKS, Kobara B, Nitschke J, Wiedemann FX, Kere AB, Adjei O, Löscher T, Fleischer B,Bretzel G, Herbinger KH. Effectiveness of Routine BCG Vaccination on Buruli UlcerDisease: A Case-Control Study in the Democratic Republic of Congo, Ghana andTogo. PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3457. doi:
• 10.1371/journal.pntd.0003457. eCollection 2015 Jan. PubMed PMID: 25569674; PubMedCentral PMCID: PMC4287572. 
  >>Read